Source:http://linkedlifedata.com/resource/pubmed/id/20375411
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
14
|
| pubmed:dateCreated |
2010-4-8
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
1533-4406
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:day |
8
|
| pubmed:volume |
362
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1335-7
|
| pubmed:meshHeading |
pubmed-meshheading:20375411-Antimetabolites, Antineoplastic,
pubmed-meshheading:20375411-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20375411-Biliary Tract Neoplasms,
pubmed-meshheading:20375411-Cisplatin,
pubmed-meshheading:20375411-Deoxycytidine,
pubmed-meshheading:20375411-Humans,
pubmed-meshheading:20375411-Research Design
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
A step forward in the treatment of advanced biliary tract cancer.
|
| pubmed:publicationType |
Editorial,
Comment
|